Medtronic Presents Data To Boost Hugo’s Odds Of Getting FDA Nod

Medtronic says results from a recent study on the Hugo robotic-assisted surgery system substantiate its safety and effectiveness for various urological procedures. The company also announced it has submitted the system to the FDA for approval for a urological indication.

(Brian Bossetta)

More from Robotic Surgery

More from North America